Отчет об анализе размера, доли и тенденций мирового рынка устройств масс-спектрометрии — обзор отрасли и прогноз до 2031 года

Анализ рынка масс-спектрометрических приборов

Рынок масс-спектрометрических устройств продолжает развиваться с достижениями в области визуализации высокого разрешения, повышенной чувствительности и более быстрого анализа. Приложения охватывают фармацевтику, мониторинг окружающей среды и клиническую диагностику. Такие инновации, как MALDI-TOF и тройные квадрупольные системы, стимулируют рост, решая сложные аналитические задачи. Расширение рынка подпитывается растущим спросом на прецизионную медицину и контроль качества в различных отраслях.  

Размер рынка масс-спектрометрических устройств

Объем мирового рынка масс-спектрометрических устройств в 2023 году оценивался в 6,97 млрд долларов США, а к 2031 году, по прогнозам, он достигнет 11,34 млрд долларов США, при среднегодовом темпе роста 6,27% в прогнозируемый период с 2024 по 2031 год. Помимо аналитических данных о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Область отчета и сегментация рынка

Mass Spectrometry Devices Market Definition

Mass spectrometry devices analyze chemical substances by measuring their mass-to-charge ratios and producing mass spectra. These instruments are crucial in various fields such as chemistry, biochemistry, and environmental science for identifying compounds, quantifying molecules, and studying molecular structures. They operate by ionizing samples, separating ions based on mass, and detecting ion signals to provide detailed molecular information with high sensitivity and accuracy.            

Mass Spectrometry Devices Market Dynamics

Drivers

• Growing Adoption in Proteomics and Metabolomics

The growing adoption of mass spectrometry in proteomics and metabolomics research is driving market demand. These techniques are essential for studying proteins and metabolites, crucial in biomarker discovery for diseases such as cancer. For instance, mass spectrometry enables precise identification and quantification of biomarkers in patient samples, facilitating personalized medicine approaches. This capability supports advancements in metabolic profiling, enhancing understanding and treatment strategies, thereby fueling the expansion of mass spectrometry device usage.

• Increasing Drug Development Activities

The pharmaceutical industry's expanding pipeline of new drug candidates necessitates advanced analytical tools for precise drug characterization and quality assurance. Mass spectrometry devices play a pivotal role in this process by enabling detailed analysis of drug compounds, metabolites, and impurities. For instance, mass spectrometers are crucial in determining the purity and structural integrity of biopharmaceuticals, ensuring regulatory compliance and enhancing drug efficacy and safety profiles, thereby driving significant growth in the market.

Opportunities

• Increasing Research and Development

The increasing investments in research and development by pharmaceutical and biotechnology companies create significant opportunities in the mass spectrometry market. These firms rely on high-performance analytical tools such as mass spectrometers for advancing drug discovery, proteomics, and metabolomics studies. For instance, the development of novel biomarkers and precision medicine approaches requires sophisticated mass spectrometry technologies, driving the demand for innovative solutions and expanding the market's growth potential.

• Increasing Drug Development Activities

Increasing drug development activities in the pharmaceutical industry necessitate advanced analytical tools such as mass spectrometry for drug characterization and quality control. This demand creates opportunities for market growth as companies seek precise and reliable methods to ensure the safety and efficacy of new drug candidates. For instance, mass spectrometry facilitates the accurate determination of drug purity and the detection of impurities, crucial for meeting regulatory standards and advancing drug development processes.

Restraints/Challenges

• High Initial Costs

The high initial costs associated with mass spectrometry devices pose a significant barrier to market entry and adoption, particularly for smaller laboratories and research facilities. These expenses encompass both purchase and maintenance, limiting affordability and accessibility. As a result, many potential users are unable to justify the investment, hindering widespread adoption and market expansion. 

• Sample Preparation Challenges

Sample preparation for mass spectrometry poses significant challenges due to its complexity and variability. The intricate procedures required to achieve accurate results lead to inconsistencies in sample quality and preparation techniques. This variability undermines the reliability and consistency of outcomes, hindering the mass spectrometry market's growth and adoption. Such challenges necessitate meticulous attention to detail and rigorous standardization efforts to mitigate potential drawbacks in analytical accuracy and data interpretation. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Mass Spectrometry Devices Market Scope

The market is segmented on the basis technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Hybrid Mass Spectrometry
  • Triple Quadrupole (tandem)
  •  Quadrupole TOF (Q-TOF)
  •  Fourier Transform Mass Spectrometry (FTMS)
  • FT-ICR MS
  • Orbit-Rap
• Single Mass Spectrometry
  • ION Trap
  •  Quadrupole and Time-of-Flight (TOF)
• Others

Application

• Biotechnology
• Clinical Research
• Diagnostics and Environmental Testing
• Drug Discovery
• Metabolomics
• Pharmaceutical
• Proteomics
• Others

 End-User

• Institutes and Research Centers
• Medical
• Pharmaceutical and Biopharmaceutical Companies
• Suppliers and Distributors of Mass Spectrometry System
• Others

Mass Spectrometry Devices Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, technology, application and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the mass spectrometry devices market, driven by increased research funding. Government initiatives and widespread applications in metabolomics and petroleum sectors will bolster growth in the region during the forecast period.

Asia-Pacific is projected to observe significant growth in the mass spectrometry devices market due to increased demand for advanced MS devices. Rising awareness is expected to further propel market growth in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Mass Spectrometry Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Agilent Technologies, Inc. (U.S.)
• Danaher Corporation (U.S.)
• Waters Corporation (U.S.)
• Bruker (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• PerkinElmer Inc. (U.S.)
• Shimadzu Corporation (Japan)
•  KORE TECHNOLOGY (Japan)
•  LECO Corporation (U.S.)
• JEOL Ltd. (Japan)
• Eurofins Scientific (Luxembourg)
• Ion Science Ltd (U.K.)
• Teledyne FLIR LLC (США)
• AMETEK.Inc. (США)
• Hiden Analytical (Великобритания)

Последние разработки на рынке масс-спектрометрических приборов

• В июне 2023 года компания Thermo Fisher Scientific, Inc. представила масс-спектрометр Thermo ScientificTM OrbitrapTM AstralTM. Этот передовой анализатор обеспечивает точную идентификацию белков, что имеет решающее значение для революционных открытий в области клинических биомаркеров, заболеваний и методов лечения.
• В июне 2023 года компания Agilent Technologies, Inc. представила решения Inspirational LC/TQ и LC/Q-TOF Mass Spectrometry Solutions. Agilent 6495 Triple Quadrupole LC/MS отличается целевым анализом и исключительной чувствительностью. Система Agilent Revident Quadrupole Time-of-Flight LC/MS (LC/QTOF) отличается интеллектуальной архитектурой для повышения эффективности и производительности работы.
• В июне 2022 года компания Shimadzu Scientific Instruments выпустила жидкостный хроматографический квадрупольный масс-спектрометр LCMS-2050. Он отличается компактностью, высокой скоростью и высокой чувствительностью анализа.
• В марте 2022 года Waters Corporation выпустила систему Xevo TQ Absolute — компактный настольный тандемный масс-спектрометр. Обладая в 15 раз большей чувствительностью для количественного определения отрицательно ионизирующих соединений, чем его предшественник, он также уменьшает размер на 45% и снижает потребление электроэнергии и газа до 50%

SKU-1383